Manulife (Manufacturers Life Insurance)
NMRA icon

Manulife (Manufacturers Life Insurance)’s Neumora Therapeutics NMRA Stock Holding History

Manulife (Manufacturers Life Insurance)’s Portfolio NMRA Stock Details NMRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-33,671
Closed -$33.7K – 2973
2025
Q1 		$33.7K Sell
33,671
-11,389
-25% -$19.5K ﹤0.01% 2865
2024
Q4 		$478K Sell
45,060
-64,742
-59% -$776K ﹤0.01% 2268
2024
Q3 		$1.45M Sell
109,802
-2,026
-2% -$23.6K ﹤0.01% 1721
2024
Q2 		$1.1M Buy
111,828
+49,527
+79% +$512K ﹤0.01% 1809
2024
Q1 		$857K Buy
+62,301
New +$1.01M ﹤0.01% 1933

Other funds holding NMRA

SoftBank Group
SoftBank Group Tokyo, Japan $11.4B AUM 27.91% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
MCMU
MIC Capital Management (UK) London, United Kingdom $352M AUM 0.23% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
WT
Wellcome Trust London, United Kingdom $9.01B AUM 12.05% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
IC
Iconiq Capital San Francisco, California $4.46B AUM 22.86% 1-Year Est. Return
LC
Lunate Capital Al Maryah Island, Abu Dhabi, United Arab Emirates $196M AUM 84.21% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Manulife (Manufacturers Life Insurance)'s NMRA Position: Q2 2025 in Review

Manulife (Manufacturers Life Insurance) sold out of Neumora Therapeutics (NMRA) in Q2 2025, closing a stake of 33,671 shares — an estimated $33.7K sold.

Manulife (Manufacturers Life Insurance) first reported a position in NMRA in Q1 2024 and held it in 5 quarters. The position peaked at $1.45M in Q3 2024. 98 funds tracked by Wall St. Rank hold NMRA as of Q2 2025.

  • Manulife (Manufacturers Life Insurance) reported no remaining Neumora Therapeutics position as of Q2 2025 after selling out during the quarter.
  • Manulife (Manufacturers Life Insurance) sold 33,671 Neumora Therapeutics shares in Q2 2025, an estimated $33.7K.
  • Manulife (Manufacturers Life Insurance) first reported a position in Neumora Therapeutics in Q1 2024 and held it in 5 quarters.
  • Manulife (Manufacturers Life Insurance)'s Neumora Therapeutics position peaked at $1.45M in Q3 2024.
  • 98 funds tracked by Wall St. Rank held Neumora Therapeutics as of Q2 2025.

Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q2 2025, filed 14 Aug 2025.